Patients with cancer frequently receive broad-spectrum antibiotics, even if they are at low risk for antimicrobial-resistant infections.A computer prompt that notifies clinicians that a patient would not benefit from these extended-spectrum drugs could significantly curtail their use.A subgroup analysis of the four randomized Intelligent Stewardship Prompts to Improve Real-Time Empiric Antibiotic Selection (INSPIRE) trials showed that most patients with cancer…
Source: Healio News
